| Serial Number | 88397912 |
| Word Mark | DRUGOME |
| Filing Date | Tuesday, April 23, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 23, 2020 |
| Registration Number | 6083085 |
| Registration Date | Tuesday, June 23, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 7, 2020 |
| Goods and Services | Downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; downloadable computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; downloadable computer software for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest |
| Pseudo Mark | DRUG O ME |
| Goods and Services | Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials |
| Goods and Services | Advertising; business management; business administration; office functions; business research services in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials, and post-market data; business information services; market research; provision of market research information; data processing services; analysis of business data; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes |
| Goods and Services | Scientific and technological services, namely, scientific research and analysis in the field of pharmaceuticals and biomedicine; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for conducing scientific research and analysis in the fields of public health, healthcare, pharmaceutical and biomedical research, clinical trial data and data from examinations carried out after the introduction of medicines on the market; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; Artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 8, 2019 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 8, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 8, 2019 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 8, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SUMITOMO PHARMA CO. LTD. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | OSAKA 541-0045 JP |
| Party Name | SUMITOVANT BIOPHARMA, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | NEW YORK, NY 10036 |
| Party Name | SUMITOVANT BIOPHARMA, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NEW YORK, NY 10036 |
| Party Name | Roivant Sciences GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Party Name | Roivant Sciences GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Wednesday, January 24, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, September 6, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, September 6, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 6, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, September 6, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, September 6, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, June 23, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 7, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 7, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 25, 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, March 18, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 3, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 25, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 25, 2020 | ASSIGNED TO LIE |
| Tuesday, February 25, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 25, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 25, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, February 10, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, February 4, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Tuesday, January 21, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 11, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 11, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 11, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 11, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 11, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 11, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, June 3, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, May 8, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 26, 2019 | NEW APPLICATION ENTERED |